A Multicentre, Randomised, Single-blind, Controlled Protocol to Evaluate the Efficacy of Early Administration of Botulinum Toxin for Primary Midline Closure in Patients With Open Abdomen.
PHASE4Not yet recruitingINTERVENTIONAL
Enrollment
50
Participants
Timeline
Start Date
January 31, 2025
Primary Completion Date
June 30, 2026
Study Completion Date
December 31, 2026
Conditions
Botulinum Toxin Type AOpen AbdomenAbdominal WallClinical Trial
Interventions
DRUG
Botulinum Toxin A
Botulinum Toxin
OTHER
CONTROL
Saline Solution
All Listed Sponsors
lead
Instituto de Investigación Hospital Universitario La Paz